Literature DB >> 28921311

Respiratory and cardiovascular effects of fentanyl during propofol-induced sedation under spinal anesthesia.

Satoru Tanaka1, Hideaki Tsuchida1, Hajime Sonoda2, Akiyoshi Namiki1.   

Abstract

PURPOSE: To determine whether fentanyl augments respiratory and cardiovascular problems during propofol-induced sedation, we investigated the effects of propofol and fentanyl on respiratory and hemodynamic profiles in 30 female patients under spinal anesthesia, administering oxygen via face mask.
METHODS: After spinal anesthesia, 20 patients were sedated with propofol (0.5 mg·kg-1 bolus, 3 mg·kg-1·h-1), followed by administration of either 2 μg·kg-1 fentanyl in group PF or normal saline in group P, whereas another 10 patients (group F) received 2 μg·kg-1 fentanyl without propofol. We measured heart rate, mean arterial pressure, end-tidal carbon dioxide tension, and respiratory rate before and after treatment. We also evaluated apnea, arterial oxygen desaturation, and airway obstruction.
RESULTS: Mean arterial pressure was significantly lower in group P and PF than in group F. However, there were comparable changes in heart rate in the three groups. The combination of fentanyl and propofol decreased respiratory rate and increased end-tidal carbon dioxide tension more than fentanyl or propofol alone. Although apnea occurred in groups F and PF, arterial oxygen desaturation did not occur in any of the groups.
CONCLUSION: The combination of fentanyl and propofol augmented the risks of respiratory depression and apnea compared with the use of fentanyl or propofol alone.

Entities:  

Keywords:  Airway obstruction; Apnea; Fentanyl; Propofol; Sedation

Year:  1998        PMID: 28921311     DOI: 10.1007/BF02481725

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  10 in total

1.  Magnetic resonance imaging of the upper airway. Effects of propofol anesthesia and nasal continuous positive airway pressure in humans.

Authors:  M Mathru; O Esch; J Lang; M E Herbert; G Chaljub; B Goodacre; E vanSonnenberg
Journal:  Anesthesiology       Date:  1996-02       Impact factor: 7.892

2.  Frequent hypoxemia and apnea after sedation with midazolam and fentanyl.

Authors:  P L Bailey; N L Pace; M A Ashburn; J W Moll; K A East; T H Stanley
Journal:  Anesthesiology       Date:  1990-11       Impact factor: 7.892

3.  Hemodynamic response to induction and intubation. Propofol/fentanyl interaction.

Authors:  V Billard; F Moulla; J L Bourgain; A Megnigbeto; D R Stanski
Journal:  Anesthesiology       Date:  1994-12       Impact factor: 7.892

4.  Effects of combining propofol and alfentanil on ventilation, analgesia, sedation, and emesis in human volunteers.

Authors:  D J Pavlin; B Coda; D D Shen; J Tschanz; Q Nguyen; R Schaffer; G Donaldson; R C Jacobson; C R Chapman
Journal:  Anesthesiology       Date:  1996-01       Impact factor: 7.892

5.  Propofol-nitrous oxide versus thiopental-isoflurane-nitrous oxide for general anesthesia.

Authors:  V A Doze; A Shafer; P F White
Journal:  Anesthesiology       Date:  1988-07       Impact factor: 7.892

6.  Disposition of propofol administered as constant rate intravenous infusions in humans.

Authors:  E Gepts; F Camu; I D Cockshott; E J Douglas
Journal:  Anesth Analg       Date:  1987-12       Impact factor: 5.108

7.  Propofol for intravenous sedation.

Authors:  N Mackenzie; I S Grant
Journal:  Anaesthesia       Date:  1987-01       Impact factor: 6.955

8.  Propofol depresses the hypoxic ventilatory response during conscious sedation and isohypercapnia.

Authors:  R T Blouin; H A Seifert; H D Babenco; P F Conard; J B Gross
Journal:  Anesthesiology       Date:  1993-12       Impact factor: 7.892

9.  Sedation during spinal anaesthesia: comparison of propofol and midazolam.

Authors:  E Wilson; A David; N MacKenzie; I S Grant
Journal:  Br J Anaesth       Date:  1990-01       Impact factor: 9.166

10.  Some ventilatory effects of propofol as sole anaesthetic agent.

Authors:  N W Goodman; A M Black; J A Carter
Journal:  Br J Anaesth       Date:  1987-12       Impact factor: 9.166

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.